The lesson of Bill Ackman’s $3 billion loss on Valeant Pharmaceuticals By: MarketWatch March 14, 2017 at 15:38 PM EDT We investors must know when to be patient and when to be realistic, writes Cody Willard. Read More >> Related Stocks: Fitbit Inc Herbalife Ltd Valeant Pharmaceuticals International, Inc.